亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車
企業(yè)會(huì)員第1年

合肥賽曼諾生物科技有限公司  

肽核酸,類肽和多肽定制合成服務(wù)以及肽核酸單體,類肽單體

搜索
網(wǎng)站公告
合肥賽曼諾生物科技有限公司是專注于固相合成方法學(xué)研究的專業(yè)化高科技公司。賽曼諾具有多年的固相合成研究開發(fā)生產(chǎn)經(jīng)驗(yàn)。賽曼諾致力于為全球范圍內(nèi)的客戶提供包括肽核酸,類肽和多肽定制合成服務(wù)以及肽核酸單體,類肽單體。
新聞中心
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:周沐
  • 電話:0551-65326643
  • 郵件:info@cellmano.com
  • QQ:1761863581
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > L-Anserine · nitrate
L-Anserine · nitrate
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 安徽合肥市付款后3天內(nèi)
庫存 1000mg起訂5mg
品牌 賽曼諾生物
過期 長(zhǎng)期有效
更新 2015-02-13 13:12
 
詳細(xì)信息
 
A-2101 L-Anserine · nitrate C10H16N4O3 · HNO3 303.28 10030-52-1 H-β-Ala-His(3-Me)-OH · nitrate
A-2102 Carcinine C8H14N4O 182.23 56897-53-1 H-β-Ala-histamine
Hydrochloride salt 
A-2103 L-Carnosine C9H14N4O3 226.24 305-84-0 H-β-Ala-His-OH
A-2104   C31H54N12O7S2 770.98 159147-88-3 H-Pro-His-Cys-Lys-Arg-Met-OH
A-2105   C83H125N23O19 1749.05   H-Pro-Phe-Thr-Arg-Asn-Tyr-Tyr-Val-Arg-Ala-Val-Leu-His-Leu-OH
A-2106   C57H91N17O15 1254.46   H-Thr-Arg-Asn-Tyr-Tyr-Val-Arg-Ala-Val-Leu-OH
A-2201 Anxiety Peptide, Octadecaneuropeptide, ODN C81H138N24O29 1912.13 95237-86-8 H-Gln-Ala-Thr-Val-Gly-Asp-Val-Asn-Thr-Asp-Arg-Pro-Gly-Leu-Leu-Asp-Leu-Lys-OH
Acetate salt 
A-2301 Apelin-12 (human, bovine, mouse, rat)
(Des-Gln1)-Apelin-13 (human, bovine, mouse, rat), Apelin Precursor (66-77) (human, bovine, mouse, rat), Preproapelin (66-77) (human, bovine, mouse, rat)
C64H103N21O14S 1422.72 229961-08-4 H-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH
A-2302 Apelin-13 (human, bovine, mouse, rat) C69H111N23O16S 1550.85 217082-58-1 H-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH
A-2302-2 (Ala13)-Apelin-13 (human, bovine, mouse, rat) C63H107N23O16S 1474.75 568565-11-7 H-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Ala-OH
Trifluoroacetate salt 
©2025 合肥賽曼諾生物科技有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:7656  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |